• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

脂蛋白(a)与2型糖尿病之间的关联：一项孟德尔随机化研究。

Association between Lp(a) and T2D: a Mendelian randomization study.

作者信息

Goławski Marcin, Lejawa Mateusz, Banach Maciej, Jóźwiak Jacek, Gierlotka Marek, Osadnik Tadeusz

机构信息

Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland.

Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.

出版信息

Arch Med Sci. 2024 Apr 20;20(3):1002-1005. doi: 10.5114/aoms/187774. eCollection 2024.

DOI:10.5114/aoms/187774
PMID:39050158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11264145/
Abstract

INTRODUCTION

Blood lipoprotein(a) (Lp(a)) levels have been observed to be inversely correlated with type 2 diabetes (T2D). In this Mendelian randomization (MR) study, the causal impact of genetically predicted Lp(a) on T2D was assessed.

METHODS

A two-sample MR analysis was conducted. Data were obtained from UK Biobank and FinnGen consortia. Primary analysis was based on an inverse-variance-weighted mean (IVM) approach.

RESULTS

No statistically significant association between the genetically predicted levels of Lp(a) and T2D was detected ( = 0.362) in IVM analysis involving data of 563,420 patients.

CONCLUSIONS

Genetically predicted Lp(a) concentration does not appear to be causally related to the risk of T2D.

摘要

引言

已观察到血液脂蛋白(a)（Lp(a)）水平与2型糖尿病（T2D）呈负相关。在这项孟德尔随机化（MR）研究中，评估了基因预测的Lp(a)对T2D的因果影响。

方法

进行了两样本MR分析。数据来自英国生物银行和芬兰基因组联盟。主要分析基于逆方差加权均值（IVM）方法。

结果

在涉及563420名患者数据的IVM分析中，未检测到基因预测的Lp(a)水平与T2D之间存在统计学显著关联（ = 0.362）。

结论

基因预测的Lp(a)浓度似乎与T2D风险无因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb70/11264145/6d0b7a10a506/AMS-20-3-187774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb70/11264145/6d0b7a10a506/AMS-20-3-187774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb70/11264145/6d0b7a10a506/AMS-20-3-187774-g001.jpg

相似文献

1
Association between Lp(a) and T2D: a Mendelian randomization study.脂蛋白(a)与2型糖尿病之间的关联：一项孟德尔随机化研究。
Arch Med Sci. 2024 Apr 20;20(3):1002-1005. doi: 10.5114/aoms/187774. eCollection 2024.
2
Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease.极低脂蛋白(a)水平与新发糖尿病和非酒精性肝病风险的关联。
Atheroscler Plus. 2024 Jul 11;57:19-25. doi: 10.1016/j.athplu.2024.07.001. eCollection 2024 Sep.
3
Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin.脂蛋白(a)水平与2型糖尿病之间的关联：无证据表明脂蛋白(a)和胰岛素存在因果关系。
Acta Diabetol. 2017 Nov;54(11):1031-1038. doi: 10.1007/s00592-017-1036-4. Epub 2017 Sep 2.
4
Diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomization study.糖尿病和特发性肺纤维化：一项孟德尔随机化研究。
BMC Pulm Med. 2024 Mar 20;24(1):142. doi: 10.1186/s12890-024-02961-7.
5
Type 2 Diabetes and Atrial Fibrillation: Evaluating Causal and Pleiotropic Pathways Using Mendelian Randomization.2 型糖尿病与心房颤动：基于孟德尔随机化评估因果和多效通路。
J Am Heart Assoc. 2023 Sep 5;12(17):e030298. doi: 10.1161/JAHA.123.030298. Epub 2023 Aug 23.
6
The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?循环脂蛋白(a)与 2 型糖尿病之间的关联：这是因果关系吗？
Diabetes. 2014 Jan;63(1):332-342. doi: 10.2337/db13-1144. Epub 2013 Oct 2.
7
Circulating lipoprotein(a) levels and health outcomes: Phenome-wide Mendelian randomization and disease-trajectory analyses.循环脂蛋白(a)水平与健康结局：表型全基因组 Mendelian 随机化和疾病轨迹分析。
Metabolism. 2022 Dec;137:155347. doi: 10.1016/j.metabol.2022.155347. Epub 2022 Nov 15.
8
Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis.脂蛋白(a)水平长期升高与父母寿命、无慢性病生存和死亡风险的关联：一项孟德尔随机化分析。
JAMA Netw Open. 2020 Feb 5;3(2):e200129. doi: 10.1001/jamanetworkopen.2020.0129.
9
Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study.基因预测的高血压、抗高血压药物与勃起功能障碍风险：一项孟德尔随机化研究
Front Cardiovasc Med. 2023 Jun 9;10:1157467. doi: 10.3389/fcvm.2023.1157467. eCollection 2023.
10
Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.载脂蛋白(a) [脂蛋白(a)]水平对缺血性卒中和阿尔茨海默病的因果效应：一项孟德尔随机化研究。
Stroke. 2019 Dec;50(12):3532-3539. doi: 10.1161/STROKEAHA.119.026872. Epub 2019 Oct 10.

引用本文的文献

1
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.2024年：心血管疾病之年——脂蛋白(a)之年。研究进展与新发现。
Arch Med Sci. 2025 Feb 22;21(2):355-373. doi: 10.5114/aoms/202213. eCollection 2025.
2
Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action?脂蛋白(a)与动脉粥样硬化负荷——在采取行动之前我们应该等待临床试验证据吗？
Atheroscler Plus. 2024 Sep 26;58:16-23. doi: 10.1016/j.athplu.2024.09.004. eCollection 2024 Dec.
3
Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study.

本文引用的文献

1
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.波兰心脏病学会（PCS）和波兰脂质协会（PoLA）专家关于脂蛋白(a)水平升高的诊断和管理的建议。
Arch Med Sci. 2024 Jan 31;20(1):8-27. doi: 10.5114/aoms/183522. eCollection 2024.
2
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?2023年：心血管疾病之年——新型及前瞻性降脂疗法之年。到2024年我们能让血脂异常成为罕见病吗？
Arch Med Sci. 2023 Nov 2;19(6):1602-1615. doi: 10.5114/aoms/174743. eCollection 2023.
3
高加索人群中胰岛素与 Lp(a)水平之间的因果关系：一项孟德尔随机化研究。
Cardiovasc Diabetol. 2024 Aug 29;23(1):316. doi: 10.1186/s12933-024-02389-7.
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study.
脂蛋白(a)、代谢特征与家族性混合型高脂血症患者 2 型糖尿病新发病例：一项 9 年随访研究。
J Clin Lipidol. 2023 Jul-Aug;17(4):512-518. doi: 10.1016/j.jacl.2023.05.103. Epub 2023 Jun 3.
4
FinnGen provides genetic insights from a well-phenotyped isolated population.FinnGen 为一个表型良好的隔离人群提供了遗传学方面的见解。
Nature. 2023 Jan;613(7944):508-518. doi: 10.1038/s41586-022-05473-8. Epub 2023 Jan 18.
5
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy.针对脂蛋白(a)的靶向治疗：降脂治疗的即将到来的突破。
Pharmaceuticals (Basel). 2022 Dec 16;15(12):1573. doi: 10.3390/ph15121573.
6
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄：欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
7
Lipoprotein (a) and diabetes mellitus.脂蛋白（a）与糖尿病。
Atherosclerosis. 2022 May;349:63-71. doi: 10.1016/j.atherosclerosis.2022.04.016.
8
What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?脂蛋白(a)在被发现后的 57 年里，我们对其在动脉粥样硬化形成中的作用了解多少？
Prog Cardiovasc Dis. 2020 May-Jun;63(3):219-227. doi: 10.1016/j.pcad.2020.04.004. Epub 2020 Apr 8.
9
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.检测复杂性状和疾病之间的孟德尔随机化因果关系推断中广泛存在的水平 pleiotropy。
Nat Genet. 2018 May;50(5):693-698. doi: 10.1038/s41588-018-0099-7. Epub 2018 Apr 23.
10
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.基于零模态异质性假设的汇总数据孟德尔随机化的稳健推断。
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998. doi: 10.1093/ije/dyx102.